Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

LSDI | Lucy Scientific Discovery Inc

Index- P/E- EPS (ttm)- Insider Own35.04% Shs Outstand16.06M Perf Week-13.04%
Market Cap9.80M Forward P/E- EPS next Y-0.14 Insider Trans0.00% Shs Float10.62M Perf Month6.95%
Income- PEG- EPS next Q-0.07 Inst Own4.43% Short Float / Ratio0.61% / 0.54 Perf Quarter-47.83%
Sales- P/S- EPS this Y69.01% Inst Trans- Short Interest0.07M Perf Half Y-46.90%
Book/sh0.36 P/B1.65 EPS next Y34.09% ROA- Target Price1.40 Perf Year-
Cash/sh0.21 P/C2.86 EPS next 5Y- ROE- 52W Range0.55 - 4.00 Perf YTD-79.93%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-85.00% Beta-
Dividend %- Quick Ratio2.37 Sales past 5Y0.00% Gross Margin- 52W Low9.09% ATR0.07
Employees- Current Ratio2.37 Sales Q/Q- Oper. Margin- RSI (14)39.02 Volatility9.43% 12.44%
OptionableNo Debt/Eq0.30 EPS Q/Q-260.60% Profit Margin- Rel Volume1.24 Prev Close0.59
ShortableYes LT Debt/Eq0.23 Earnings- Payout- Avg Volume121.59K Price0.60
Recom1.00 SMA20-6.81% SMA50-24.79% SMA200-49.78% Volume150,904 Change1.92%
Sep-26-23 08:30AM
Sep-20-23 08:30AM
Sep-15-23 09:30AM
Sep-13-23 01:37AM
11:20PM Loading…
Sep-12-23 11:20PM
Sep-08-23 08:30AM
Sep-07-23 10:30AM
Jul-31-23 06:00AM
Jul-20-23 08:40AM
Jul-14-23 09:13AM
09:14AM Loading…
Jul-13-23 09:14AM
Jul-11-23 09:00AM
Jul-05-23 09:00AM
Jun-30-23 09:28AM
Jun-29-23 02:50PM
Jun-09-23 04:48PM
Jun-06-23 04:30PM
Jun-05-23 09:00AM
May-22-23 09:00AM
May-19-23 02:50PM
May-18-23 09:00AM
Apr-06-23 09:00AM
09:00AM Loading…
Mar-29-23 09:00AM
Mar-27-23 12:49PM
Mar-23-23 09:00AM
Mar-21-23 09:00AM
Mar-17-23 09:00AM
Feb-27-23 10:25AM
Feb-22-23 09:00AM
Feb-16-23 03:45PM
Feb-13-23 04:05PM
Feb-08-23 05:40PM
Lucy Scientific Discovery, Inc. operates as a psychotropics contract manufacturing company. It is focused on contract research, development and manufacture of psychotropic compounds. The firm supports researchers, clinicians, and drug manufacturers through the development of enabling technologies and the production of current good manufacturing practices-grade psychotropic compounds. The company was founded on February 17, 2017 and is headquartered in Victoria, Canada.